Company profile: Ceva Santé Animale
1.1 - Company Overview
Company description
- Provider of veterinary pharmaceutical products and vaccines for companion and farm animals, spanning research, development, production and marketing. Portfolio includes wildlife rabies control via ONRAB oral vaccine for skunks and raccoons, and CARDALIS (spironolactone/benazepril) for canine heart conditions. Also supports welfare and social programs and funds applied wildlife health research through the Ceva Wildlife Research Fund.
Products and services
- ONRAB®: A rabies glycoprotein recombinant oral vaccine engineered for wildlife, specifically striped skunks, and potentially raccoons and skunks in the USA, to control rabies in these populations
- CARDALIS®: A combination-therapy pharmaceutical comprising spironolactone and benazepril used to treat heart conditions in dogs, forming part of Ceva’s U.S. cardiology portfolio for companion animals
- Ceva Wildlife Research Fund: An applied-research endowment dedicated to financing studies that preserve wild animal health and prevent zoonotic diseases across wildlife populations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Ceva Santé Animale
Delacon
HQ: Austria
Website
- Description: Provider of plant-based phytogenic feed additives for poultry (broilers and layers) and other livestock, including Biostrong 510, Biostrong Protect and Biostrong Comfort to support feed conversion, growth performance, intestinal health and feed intake, including during heat stress. Operates the Performing Nature Research Center for in vivo trials and offers microencapsulation for controlled release in the gastrointestinal tract.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Delacon company profile →
PetVivo
HQ: United States
Website
- Description: Provider of biocompatible, self-assembling medical implants that mimic tissue structure and composition. Offers intra-articular injectable veterinary devices, including Kush Canine and Spryng™ with OsteoCushion™ Technology, to manage lameness, joint pain, and osteoarthritis in cats, dogs, and horses by addressing the root cause of missing or damaged cartilage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PetVivo company profile →
My Dairy Dashboard
HQ: United States
Website
- Description: Provider of a data visualization platform for the dairy industries, offering dairy management software, milk processor data, feed software, and weather updates, enabling clients to connect data sources to view trends, benchmark client herds, and receive alerts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full My Dairy Dashboard company profile →
Fullwood Packo
HQ: United Kingdom
Website
- Description: Provider of milking machines and milk storage and cooling equipment; a manufacturing company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fullwood Packo company profile →
Genus
HQ: United Kingdom
Website
- Description: Provider of pioneering animal genetic improvement to help nourish the world.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genus company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Ceva Santé Animale
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Ceva Santé Animale
2.2 - Growth funds investing in similar companies to Ceva Santé Animale
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Ceva Santé Animale
4.2 - Public trading comparable groups for Ceva Santé Animale
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →